Companies · Other Health Care

Neuro Force One. Inc.

SCOTTSDALE · Other Health Care

Diligence memoA one-page analyst read on Neuro Force One. Inc. — recommendation, valuation, rhythm, risks.
$200K
Total raised · real
2
Rounds
1.0×
Latest step-up
Top 92%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Neuro Force One. Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.31× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
  • Issuer reports $0–$1M revenue while modeled below niche peers.
Dormant
  • Last raise 5.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Neuro Force One. Inc. is one of 5377 Other Health Care companies tracked from SCOTTSDALE. By capital raised it ranks in the long tail (ahead of 9% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 506(b)
Reg D exemption
3
Investors (latest)
2019
Year incorporated
2020-11-17
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3M$2.5M$3.8M$5.0MPre-Seed · 2019-07-01 Raised $100K (real) Modeled valuation $3.1M (est)$100K$3.1MPre-Seed2019Pre-Seed · 2020-11-17 Raised $100K (real) Modeled valuation $2.6M (est)$100K$2.6MPre-Seed2020+$100KCumulative $200K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$100K · 2019
Pre-Seed extension$100K · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$2.6M
Base estimate est.
$63K
Conservative case
$25.8M
Upside case
$556K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $3.1M · 2019-07-012019Pre-Seed · modeled $2.6M · 2020-11-172020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
5.6 yr
Elapsed time used
5.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
17 mo
Avg between rounds
$145K/yr
Capital velocity
7.0 yr
On record since
2019
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$200K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.3× of median
This company$100K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$2.6M
Sector median$22.1M

Raised more than 9% of sector peers (real $). Modeled value above 11% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #281 of 295.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)Neuro Force One. Inc. (this company) Raised $200K · modeled $2.6M (est)Neuro Force One. Inc.
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.75×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.66×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.57×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.51×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.27×
Neuro Force One. Inc. this companyPre-Seed$200K$2.6M0.31×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$100K2019-07-01$556K$3.1M90%
Pre-Seed$100K2020-11-17$556K$2.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$100K2019-07-01
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$100K2020-11-17
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 3 investors on this round.
Intelligence
2022 ~Q2
Modeled next raise · ~17mo cadence
$100K
Modeled next size est.range $100K$160K
1.0×
Last step-up
$145K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jesse Kevan2020-11
Karim Amin2019-07
Registry & provenance

Neuro Force One. Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1781962
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Advanced Patient Care LlcOther Health CarePre-Seed$200K$3.1Msame sector · same stage
Capstone Dental, Inc.Other Health CarePre-Seed$200K$3.1Msame sector · same stage
Mosie Inc.Other Health CarePre-Seed$200K$1.6Msame sector · same stage
UMS MR Fusion Services of New England, LLCOther Health CarePre-Seed$201K$1.8Msame sector · same stage
Fireside Strategic Corp.Other Health CarePre-Seed$205K$2.0Msame sector · same stage
Surgery Center at Cottonwood, LLCOther Health CarePre-Seed$208K$3.3Msame sector · same stage
Boca Raton Outpatient Surgery & Laser Center LtdOther Health CarePre-Seed$186K$3.3Msame sector · same stage
Diamond State Lithotripsy, LLCOther Health CarePre-Seed$216K$3.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
NeuroVice, Inc.Other Health CarePre-Seed$752K90%
NeuroSave, Inc.Other Health CareSeed$3.7M89%
NeuroReserve Inc.Other Health CareSeed$2.4M88%
NeuroPace IncOther Health CareSeries C$1.5B88%
Neuro Kinetics, Inc.Other Health CareSeed$6.4M88%
Neuro42, Inc.Other Health CareSeries B$96.3M88%
NeuroRescue, Inc.Other Health CarePre-Seed$5.9M87%
Neuronetics, Inc.Other Health CareSeries B$332.3M87%
Frequently asked
How much funding has Neuro Force One. Inc. raised?
Neuro Force One. Inc. has raised approximately $200K in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Neuro Force One. Inc.'s estimated valuation?
Provath's modeled valuation for Neuro Force One. Inc. is approximately $2.6M (modeled range $63K–$25.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Neuro Force One. Inc. at?
Neuro Force One. Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Nov 17.
What does Neuro Force One. Inc. do and where is it based?
Neuro Force One. Inc. operates in the Other Health Care sector, based in SCOTTSDALE.
Explore related

See where Neuro Force One. Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Neuro Force One. Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.